A Clinical and Biological Prospective Database of Patients Treated With Anticancer Immunotherapy and Follow up of Their Immune-related Adverse Events irAE

RecruitingOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

July 15, 2019

Primary Completion Date

July 15, 2029

Study Completion Date

July 15, 2029

Conditions
Cancer
Interventions
OTHER

Estimation of the incidence of the irAE

Assessment of the incidence of the irAE in patients treated with immunotherapy at the Hospices Civils de Lyon (irAE of all grades and from all organs) and creation of a biological collection of blood, plasma, serum and PBMCs from patients before treatment, under treatment and at the onset of irAEs.

Trial Locations (5)

Unknown

NOT_YET_RECRUITING

Hôpital L. Pradel, Bron

NOT_YET_RECRUITING

Hôpital Pierre Wertheimer, Bron

NOT_YET_RECRUITING

Hôpital de la Croix Rousse, Lyon

NOT_YET_RECRUITING

Hôpital E Herriot, Lyon

RECRUITING

Centre Hospitalier LYON SUD, Pierre-Bénite

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT03989323 - A Clinical and Biological Prospective Database of Patients Treated With Anticancer Immunotherapy and Follow up of Their Immune-related Adverse Events irAE | Biotech Hunter | Biotech Hunter